1. Home
  2. MAX vs DNA Comparison

MAX vs DNA Comparison

Compare MAX & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAX
  • DNA
  • Stock Information
  • Founded
  • MAX 2014
  • DNA 2008
  • Country
  • MAX United States
  • DNA United States
  • Employees
  • MAX N/A
  • DNA N/A
  • Industry
  • MAX Industrial Machinery/Components
  • DNA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MAX Industrials
  • DNA Health Care
  • Exchange
  • MAX Nasdaq
  • DNA Nasdaq
  • Market Cap
  • MAX 582.4M
  • DNA 658.5M
  • IPO Year
  • MAX 2020
  • DNA N/A
  • Fundamental
  • Price
  • MAX $10.35
  • DNA $10.24
  • Analyst Decision
  • MAX Strong Buy
  • DNA Sell
  • Analyst Count
  • MAX 6
  • DNA 3
  • Target Price
  • MAX $17.92
  • DNA $9.67
  • AVG Volume (30 Days)
  • MAX 419.3K
  • DNA 1.6M
  • Earning Date
  • MAX 07-30-2025
  • DNA 08-07-2025
  • Dividend Yield
  • MAX N/A
  • DNA N/A
  • EPS Growth
  • MAX N/A
  • DNA N/A
  • EPS
  • MAX 0.28
  • DNA N/A
  • Revenue
  • MAX $1,002,364,000.00
  • DNA $237,417,000.00
  • Revenue This Year
  • MAX $24.09
  • DNA N/A
  • Revenue Next Year
  • MAX $11.18
  • DNA $15.91
  • P/E Ratio
  • MAX $37.31
  • DNA N/A
  • Revenue Growth
  • MAX 148.62
  • DNA 13.76
  • 52 Week Low
  • MAX $7.33
  • DNA $5.00
  • 52 Week High
  • MAX $20.91
  • DNA $16.85
  • Technical
  • Relative Strength Index (RSI)
  • MAX 45.90
  • DNA 53.69
  • Support Level
  • MAX $10.05
  • DNA $8.21
  • Resistance Level
  • MAX $11.14
  • DNA $13.33
  • Average True Range (ATR)
  • MAX 0.37
  • DNA 0.92
  • MACD
  • MAX -0.07
  • DNA -0.04
  • Stochastic Oscillator
  • MAX 26.43
  • DNA 39.86

About MAX MediaAlpha Inc.

MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: